Media headlines about TeamHealth Holdings (NYSE:TMH) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. TeamHealth Holdings earned a daily sentiment score of 0.10 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.2317128577056 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

TeamHealth Holdings (NYSE:TMH) remained flat at $43.50 during midday trading on Tuesday. The stock had a trading volume of 2,028,979 shares. The stock’s 50-day moving average price is $43.38 and its 200-day moving average price is $39.50. TeamHealth Holdings has a 52 week low of $30.83 and a 52 week high of $49.50.

COPYRIGHT VIOLATION WARNING: “TeamHealth Holdings (TMH) Given News Sentiment Rating of 0.10” was originally reported by Watch List News and is owned by of Watch List News. If you are reading this report on another domain, it was stolen and republished in violation of U.S. and international copyright & trademark law. The original version of this report can be accessed at

TeamHealth Holdings Company Profile

Team Health Holdings, Inc is a United States-based physician services company. The Company supplies outsourced healthcare professional staffing and administrative services to hospitals and other healthcare providers in the United States. It operates through four segments: Hospital Based Services, IPC Healthcare, Specialty Services and Other Services.

Insider Buying and Selling by Quarter for TeamHealth Holdings (NYSE:TMH)

Receive News & Ratings for TeamHealth Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TeamHealth Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.